Drug Discovery World

OCTOBER 9, 2023

Over twenty pharma companies have rejected the UK government’s proposed changes to the statutory scheme for branded medicines, the latest move in an ongoing disagreement between the government and industry. According to the Association of the British Pharmaceutical industry (ABPI), the “radical plans” are “unworkable”.

Government 130

Government Pharma Companies Science Pharmaceuticals 130

Drug Discovery World

JULY 2, 2024

This article will examine the regional focus of the country’s life sciences industry, its infrastructure of bioparks, and how this foundation ensures Switzerland maintains its role as a global leader in drug discovery. So, in this way there is a cross fertilisation from the bigger companies to newer ones.

Science 147

Science Drugs Clinical Trials Licensing 147

Drug Discovery World

OCTOBER 6, 2022

As we start to look beyond the pandemic, which areas of Europe’s drug discovery community should we take note of? The European drug discovery sector is buoyant. With key players including AstraZeneca, Bayer, Novartis and Pfizer pushing the boundaries of drug development, the reason behind this growth is evident. Valued at $14.8

Targeted Protein Degradation 130

Targeted Protein Degradation Drugs Pharma Companies Marketing 130

Drug Discovery World

FEBRUARY 7, 2023

The top 20 biopharmaceutical companies have recorded a growth of 5.4% According to analytics company GlobalData, 11 companies indicated double-digit growth, with four companies – Merck & Co (45.3%), Vertex Pharmaceuticals (32.8%), Eli Lilly (31.6%), and AstraZeneca (21.5%) – reporting more than 20% YoY growth in market capitalisation.

Vaccine 130

Vaccine Pharma Companies Marketing Pharmaceuticals 130

Drug Discovery World

FEBRUARY 10, 2023

DDW Editor Reece Armstrong explores the Scandinavian drug discovery sector and speaks to key players about Sweden’s place in the market. Scandinavia represents one of the most exciting but perhaps underrepresented markets for the discovery and development of pharmaceuticals. A good part of half of those are within pharma.

Science 130

Science Drugs Pharmaceutical Companies Pharmaceuticals 130

Drug Target Review

SEPTEMBER 5, 2024

However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company. I am a pharmacist by training and continued with a PhD in Clinical Pharmacology.

Pharma Companies 111

Pharma Companies Licensing Licensing Disease 111

Drug Discovery World

APRIL 20, 2023

Dr Paula Moran, Dr Kiri Granger, Dr J Mark Treherne , and Dr Jenny Barnett explore the effects of long Covid-19 symptoms and what the opportunities are for drug developers working to treat post-Covid-19 cognitive impairment. However, to invest in drug development for this condition, a number of methodological issues will need to be addressed.

Drug Development 246

Drug Development Clinical Trials Drugs Virus 246

Drug Discovery World

AUGUST 22, 2023

Originator pharma companies are developing ever more complex products, which are transforming the medical landscape, but their cost places an increasing burden on healthcare budgets worldwide. This includes products with complex active ingredients or complex formulations, drug-device combination products, or complex routes of delivery.

Production 130

Production Pharma Companies Clinical Trials FDA 130

Drug Patent Watch

SEPTEMBER 17, 2023

This chart shows the drug companies with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the… The post Which pharma companies have the most supplementary protection certificates?

Pharma Companies 59

Pharma Companies Pharmaceuticals Drugs 59

Drug Discovery World

DECEMBER 27, 2023

You can also find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts. These are just some of the words that come to mind when talking about not just the drug discovery sector, but the lives of those working in and around it. He speaks about this drug discovery journey here. Developing. Listen here.

Targeted Protein Degradation 173

Targeted Protein Degradation Clinical Trials Pharma Companies Drug Development 173

Drug Discovery World

NOVEMBER 16, 2022

In April 2021, life sciences solutions provider Molecular Devices launched its Organoid Innovation Centre (OIC), an initiative designed to help scientists leverage the potential of 3D biology throughout the drug discovery process. . 2D biology has been used by pharmaceutical researchers for decades. 2D vs 3D .

Pharma Companies 243

Pharma Companies Science Research Drugs 243

Drug Discovery World

JANUARY 24, 2023

DDW Multimedia Editor Megan Thomas observes the 2023 drug discovery landscape, speaking to industry experts and looking at the foundations of 2022 on which next year will lean. In early November 2022, two Alzheimer’s drugs were tested head-to-head in a first-ever virtual clinical trial 3. We’ve shown that this type of model can work.

Clinical Trials 242

Clinical Trials Trials Drugs Treatment 242

Drug Discovery World

OCTOBER 4, 2022

DDW Editor Reece Armstrong explores some of the trends that will be featured in sessions throughout ELRIG Drug Discovery 2022 and the news behind them. Automated systems have become a prominent feature throughout drug discovery, helping scientists save time and assisting in reproducible experiments for more verifiable results.

Drugs 130

Drugs Therapies Clinical Trials Cell Based Assays 130

Drug Discovery World

MAY 1, 2024

Many of the best-selling drugs in 2023 were monoclonal antibody (mAB) therapies, including Keytruda (pembrolizumab), Humira (adalimumab), and Dupixent (dupilumab) 1. Ben Holland, Co-Founder and CTO of Antiverse, notes that AI and machine learning now touch 10% of drug discovery projects.

FDA Approval 147

FDA Approval Therapies FDA Molecular Biology 147

H1 Blog

JULY 30, 2024

This effort seeks to provide the pharmaceutical industry with more accurate representation of patient populations, thereby enhancing the safety and efficacy for prescription drugs and medical devices. Hence, pharmaceutical companies need to start making preparations to ensure compliance with the new requirements. “Now,

FDA 59

FDA Compliance Clinical Trials Pharma Companies 59

Drug Discovery World

MARCH 29, 2023

Politico published a summary of the key propositions outlined in the draft 2 , and DDW’s Multimedia Editor Megan Thomas investigates their intention, and observes how the industry has responded. Key proposals Approved drugs must launch in all EU countries within two years Politico described this as a measure to ensure a level playing field.

Clinical Trials 130

Clinical Trials Biosimilars Pharma Companies Production 130

Drug Discovery World

JULY 18, 2022

Troy Groetken of intellectual property and technology law firm McAndrews, Held & Malloy tells Lu Rahman how pharma companies can take this data from where it currently stands (drug design and development) to a more clinical level. AI and big data are now commonly involved with drug discovery and development.

Clinical Trials 130

Clinical Trials Therapies Pharmaceuticals Science 130

Drug Patent Watch

SEPTEMBER 18, 2022

This chart shows the drug companies with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the…. The post Which pharma companies have the most supplementary protection certificates?

Pharma Companies 52

Pharma Companies Pharmaceuticals Drugs 52

Drug Target Review

MARCH 15, 2024

Cultural differences between the UK and mainland Europe were still quite different then but we settled in Southampton and I later went to University in Brighton, studied for a D.Phil, and found a job at a Pharma company. How important is it to have role models for young women working in the pharmaceutical industry?

Organic Chemistry 59

Organic Chemistry Pharma Companies Clinical Trials Pharmaceuticals 59

PPD

JULY 13, 2023

At the beginning of 2023, the PPD clinical research business of Thermo Fisher Scientific surveyed 120 drug developers across the pharmaceutical, biopharmaceutical and biotechnology sectors (referred to collectively as “pharma”) to learn more about sponsors’ current needs for site and patient recruitment services.

Pharma Companies 52

Pharma Companies Clinical Trials Trials Clinical Research 52

Drug Patent Watch

SEPTEMBER 17, 2021

This chart shows the drug companies with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the…. The post Which pharma companies have the most supplementary protection certificates?

Pharma Companies 52

Pharma Companies Pharmaceuticals Drugs 52

The Pharma Data

SEPTEMBER 22, 2020

Swiss pharma company to acquire biotech for $449m (€380m). Swiss pharma company Roche is set to acquire Irish biotech firm Inflazome for an upfront payment of $449m (€380m). Activated NLRP3 is involved in the production of pro-inflammatory cytokines IL-1? Source link.

Pharma Companies 52

Pharma Companies Small Molecule Pharmaceutical Companies Disease 52

Drug Discovery World

APRIL 27, 2023

Dr Mansley also comments that the multitude of biotech and pharma companies in the Greater Boston region means that people regularly move organisations. She said: “When one of our customers leaves a company and moves to a new one up the street, they often get in touch with us, which helps us grow new business.

Small Molecule 130

Small Molecule Science Drugs FDA Approval 130

H1 Blog

MAY 4, 2023

Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Research Pharma Companies Pharmaceuticals 52

Drug Patent Watch

SEPTEMBER 16, 2020

This chart shows the drug companies with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the…. The post Which pharma companies have the most supplementary protection certificates?

Pharma Companies 52

Pharma Companies Pharmaceuticals Drugs 52

Drug Discovery World

FEBRUARY 2, 2024

From pharma to non-profit “I probably wouldn’t have the role I have now if I hadn’t worked for SLAS,” Tarselli reflects. What followed was his move from a large pharmaceutical conglomerate to a non-profit organisation. This session will ask, have you used AI and ML to generate actual outcomes for a drug process? For a patient?

Compliance 130

Compliance Science Pharma Companies Engineering 130

The Pharma Data

NOVEMBER 20, 2020

According to a benchmarking survey by TraceLink , 532 global supply chain leaders from various leading pharma companies, wholesale distributors, hospitals and pharmacies have indicated the supply chain has been severely impacted by the Covid-19 pandemic. Save your early bird seat now.

Pharma Companies 52

Pharma Companies Vaccine Pharmacy Drugs 52

DrugBaron

FEBRUARY 16, 2024

“There is more than one way to skin a cat” is a rather gruesome British idiom, but its sentiment surely applies to running a successful pharmaceutical portfolio. But not everyone in drug development is playing this game. No wonder investing in drug development is so hard! But how do you know which game you are playing?

Drug Development 355

Drug Development Pharma Companies Drugs Science 355

Drug Discovery World

SEPTEMBER 29, 2022

Challenges in outsourcing drug discovery. In this listicle, SAMDITech outlines the benefits of outsourcing models in the pharmaceutical industry, looking past perceived costs to the value outsourcing can bring. . The goal of drug discovery is clear: Identify the most promising leads in the shortest amount of time.

Small Molecule 130

Small Molecule Assay Development DNA Biochemical Assays 130

H1 Blog

NOVEMBER 15, 2023

Since KOLs play such a critical role, engaging with the right KOLs is a key strategy for pharmaceutical companies to stay ahead of the game. Compliance ensures that interactions between pharmaceutical companies and KOLs are transparent, fair, and free from any undue influence.

Compliance 59

Compliance Science Regulations Pharmaceutical Companies 59

Predictive Oncology

FEBRUARY 7, 2023

NEW YORK – Predictive Oncology wants to ink more partnerships with biopharmaceutical companies and demonstrate the ability of its commercially available PEDAL platform to provide early insights that sponsors can use to prioritize drugs for development and identify biomarker-informed indications.

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 52

Vial

MARCH 1, 2024

Introduction Contract research organizations (CROs) are essential in pharmaceutical research and development (R&D). A 2022 survey by McKinsey found that emerging biotech companies are less satisfied with their CROs than large pharma companies and reported the feeling of being underserved.

Clinical Trials 52

Clinical Trials Clinical Research Laboratories Trials 52

The Pharma Data

SEPTEMBER 14, 2020

In addition, with the pressure to reduce drug waste and react quickly to study changes, implementing inadequate risk management policies can also impact clinical supply chain performance leading to budget increases and delayed timelines. Accelerating your clinical trial supply through digitalization.

Clinical Supply 52

Clinical Supply Clinical Trials Pharma Companies Trials 52

Eye on FDA

JANUARY 9, 2022

Once again it was a quiet year with respect to the FDA’s Office of Prescription Drug Programs (OPDP). In the latest published guidance agenda from the Center for Drug Evaluation and Research, the advertising and promotion category had no slated guidance efforts listed. Why This is a Fail.

FDA 64

FDA Pharma Companies Pharmaceutical Companies Production 64

The Pharma Data

JANUARY 17, 2021

Connecticut-based Biohaven Pharmaceuticals was looking pretty hopeful with its third-generation prodrug to modulate glutamate, the most abundant excitatory neurotransmitter in the human body. Nonetheless, the company plans to advance the drug to a full Phase III program with a larger sample size and a higher-dose arm. .

Pharma Companies 52

Pharma Companies Disease Treatment Trials 52

The Pharma Data

JANUARY 4, 2021

Rothenberg did not provide any information as to what his next role may be – whether he will take over the helm of a pharma company or assume a role on one or more boards of directors. Rothenberg took over as Pfizer CMO in January 2019, but spent more than 12 years in total working for the pharmaceutical giant.

Pharma Companies 52

Pharma Companies Clinical Development Clinical Research International 52

Drug Discovery World

AUGUST 7, 2024

Ashu Singhal and Sajith Wickramasekara , co-founders of Benchling, explore how AI’s true promise for the pharmaceutical industry can only be realised if the entire pharmaceutical R&D lifecycle is supported. Drug discovery has quickly become a trendy place to apply AI.

Pharma R&D 173

Pharma R&D Clinical Trials Pharma Companies Trials 173